Examkin

Soru

Zorluk: OrtaGastroenterology and Hepatology

A gastroenterology clinic regularly screens and evaluates patients for viral hepatitis. Proper interpretation of Hepatitis B serologic panels is critical for determining the phase of infection and appropriate management. Match each of the following patient Hepatitis B serologic profiles with the most appropriate clinical interpretation.

  • Profile A: HBsAg (+), Anti-HBc IgM (+), HBeAg (+), Anti-HBs (-)Acute hepatitis B infection, highly infectious
  • Profile B: HBsAg (-), Anti-HBc IgG (+), HBeAg (-), Anti-HBs (+)Resolved prior hepatitis B infection with natural immunity
  • Profile C: HBsAg (-), Anti-HBc (-), HBeAg (-), Anti-HBs (+)Immunity isolated to previous hepatitis B vaccination
  • Profile D: HBsAg (+), Anti-HBc IgG (+), HBeAg (-), Anti-HBs (-)Chronic hepatitis B infection, inactive carrier state

Cevap

Profile A corresponds to acute hepatitis B infection (highly infectious); Profile B corresponds to resolved prior infection (natural immunity); Profile C corresponds to immunity from vaccination; Profile D corresponds to chronic hepatitis B infection (inactive carrier state).
Matching each Hepatitis B serology profile to its correct clinical state relies on evaluating the presence of specific antigens and antibodies. HBsAg indicates active infection. Anti-HBc distinguishes natural exposure (positive) from vaccination (negative), with IgM marking acute disease and IgG marking chronic or past disease. Anti-HBs represents protective immunity, and HBeAg signifies high viral replication and infectivity.

Adım Adım Çözüm

1
Evaluate the HBsAg (Surface Antigen) status.
Determines if the patient currently has the virus in their blood.
HBsAg is the primary hallmark of an active infection, whether in the acute or chronic phase.
2
Evaluate the Anti-HBc (Core Antibody) status and subtype (IgM vs. IgG).
Differentiates between acute infection (IgM), chronic or resolved infection (IgG), and vaccination (negative).
The core antigen is not present in the standard Hepatitis B vaccine, meaning Anti-HBc only develops after exposure to the natural virus.
3
Evaluate the Anti-HBs (Surface Antibody) status.
Determines if the patient has successfully achieved immunity.
Anti-HBs develops only after successful clearance of a natural infection or as an intended immune response to vaccination.
4
Evaluate the HBeAg (Envelope Antigen) status.
Determines the level of active viral replication and degree of infectivity.
HBeAg is a surrogate marker for active viral replication; its presence indicates a highly infectious state, whereas its absence in a chronic carrier points toward lower infectivity.

Anahtar Kavram

Interpretation of Hepatitis B serologic markers to determine infection phase and immunity status.
Bu soruyu puanla

Konular

Gastroenterology and Hepatology

Bu konudan daha fazla soru